Leadership

The Second Genome team is comprised of veterans of the life science and microbiome research market, and includes strong domain expertise in bringing molecular diagnostics and therapeutics to market.

 

Peter DiLaura, President & CEO

Peter has more than 15 years experience in the life sciences industry with leadership roles at Ingenuity Systems, Chemdex/Ventro and IBM, and as a consultant at The Wilkerson Group. He has a BS in Economics from the Wharton School at the University of Pennsylvania.

 

 

 

 

 

Janet Warrington PhD, Co-Founder & SVP, Operations and Development

Janet has more than 20 years in biotechnology and molecular diagnostics R&D experience. She helped build Affymetrix serving as VP of R&D, Molecular Diagnostics. She received a Ph.D. in Biological Chemistry from UC Irvine, and was a DOE Postdoctoral Scholar in Genetics at Stanford University.

 

 

 

 

 

Mohan S. Iyer, SVP Corporate Development

Mohan has over 25 years experience in the life sciences industry in a range of functions at Genentech, diaDexus, and most recently as CBO and CFO at Tethys Bioscience. He also brings experience as a management consultant, at The Wilkerson Group, and as an investment banker, at Burrill & Company. He holds an BS in Chemical Engineering from University of Tennessee, an MS in Biomedical Engineering from Duke, and an MBA from Yale University.

 

 

 

 

 

Todd Z. DeSantis, Co-Founder & Head of Bioinformatics

Todd is the chief architect for microbiome assay and analysis pipelines. He manages all bioinformatics work and oversees the planning, performance and interpretation of projects and the production of data reports. Prior to Second Genome, he was a Software Developer and Research Associate at Lawrence Berkeley National Laboratory and is chief architect of the Greengenes 16S ribosomal DNA database.